Marshall Wace’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,175
| Closed | -$653K | – | 2442 |
|
|
2024
Q1 | $653K | Buy |
2,175
+2,046
| +1,586% | +$614K | ﹤0.01% | 1603 |
|
|
2023
Q4 | $30.4K | Buy |
+129
| New | +$30.4K | ﹤0.01% | 1770 |
|
|
2023
Q3 | – | Sell |
-1,424
| Closed | -$248K | – | 2031 |
|
|
2023
Q2 | $248K | Sell |
1,424
-739
| -34% | -$129K | ﹤0.01% | 1767 |
|
|
2023
Q1 | $273K | Buy |
2,163
+74
| +4% | +$9.32K | ﹤0.01% | 1845 |
|
|
2022
Q4 | $633K | Buy |
+2,089
| New | +$633K | ﹤0.01% | 1743 |
|
|
2019
Q1 | – | Sell |
-1,583
| Closed | -$1.5M | – | 1830 |
|
|
2018
Q4 | $1.5M | Buy |
+1,583
| New | +$1.5M | 0.02% | 795 |
|